• NewGenIvf posted revenue of US$ 1.92 million for the six months ended June 30, 2026, down 5% year over year.
• Net loss attributable to shareholders widened to US$ 8.04 million from net income of US$ 724,975 a year earlier.
• Operating loss increased to US$ 3.55 million, while total other income (expenses), net deepened to a loss of US$ 8.08 million.
• Total assets rose to US$ 36.44 million at June 30, 2026, while cash and cash equivalents increased to US$ 1,023,789.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewGenIvf Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-107570), on October 07, 2026, and is solely responsible for the information contained therein.